Efficacy of Moxidectin Versus Ivermectin Against Strongyloides stercoralis Infections: A Randomized, Controlled Noninferiority Trial

Clinical Infectious Diseases

Volumn 65, Issue 2, 2017, Pages 276-281

  Barda, Beatrice ^a,b   Sayasone, Somphou ^c   Phongluxa, Khampheng ^c   Xayavong, Syda ^c   Keoduangsy, Khonsavanh ^c   Odermatt, Peter ^a,b   Puchkov, Maxim ^b   Huwyler, Jörg ^b   Hattendorf, Jan ^a,b   Keiser, Jennifer ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Ministry of Health   (Laos)

Author keywords

ivermectin; moxidectin; Opisthorchis viverrini.; Strongyloides stercoralis

Indexed keywords

ALBENDAZOLE; IVERMECTIN; MOXIDECTIN; PRAZIQUANTEL; ANTINEMATODAL AGENT; MACROLIDE; MILBEMYCIN;

ABDOMINAL DISCOMFORT; ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIARRHEA; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEADACHE; HOOKWORM INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NAUSEA; OPISTHORCHIASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SAMPLE SIZE; SINGLE DRUG DOSE; SKIN DEFECT; STRONGYLOIDIASIS; VERTIGO; ANIMAL; CLINICAL TRIAL; COMPLICATION; DRUG EFFECT; EQUIVALENCE TRIAL (TOPIC); ONCHOCERCIASIS; OPISTHORCHIS; PARASITOLOGY; SINGLE BLIND PROCEDURE; STRONGYLOIDES STERCORALIS;

ADULT; ANIMALS; ANTINEMATODAL AGENTS; COINFECTION; EQUIVALENCE TRIALS AS TOPIC; FEMALE; HUMANS; IVERMECTIN; LOST TO FOLLOW-UP; MACROLIDES; MALE; ONCHOCERCIASIS; OPISTHORCHIS; SINGLE-BLIND METHOD; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 85023180920     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix278     Document Type: Article

References (37)

1. Olsen A, van Lieshout L, Marti H, et al. Strongyloidiasis-The most neglected of the neglected tropical diseases? Trans R Soc Trop Med Hyg 2009; 103:967-72
2. Beknazarova M, Whiley H, Ross K. Advocating for both environmental and clinical approaches to control human strongyloidiasis. Pathog Basel Switz 2016; 5
3. Bisoffi Z, Buonfrate D, Montresor A, et al. Strongyloides stercoralis: a plea for action. PLoS Negl Trop Dis 2013; 7:e2214
4. Schar F, Trostdorf U, Giardina F, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis 2013; 7:e2288
5. Khieu V, Hattendorf J, Schar F, et al. Strongyloides stercoralis infection and re-infection in a cohort of children in Cambodia. Parasitol Int 2014; 63:708-12
6. Henriquez-Camacho C, Gotuzzo E, Echevarria J, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev 2016; CD007745
7. Suputtamongkol Y, Premasathian N, Bhumimuang K, et al. Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. PLoS Negl Trop Dis 2011; 5
8. Forrer A, Khieu V, Schindler C, et al. Ivermectin treatment and sanitation effectively reduce Strongyloides stercoralis infection risk in rural communities in Cambodia. PLoS Negl Trop Dis 2016; 10
9. Khieu V, Schar F, Marti H, et al. Diagnosis, treatment and risk factors of Strongyloides stercoralis in schoolchildren in Cambodia. PLoS Negl Trop Dis 2013; 7:e2035
10. Nontasut P, Muennoo C, Sa-nguankiat S, Fongsri S, Vichit A. Prevalence of strongyloides in northern Thailand and treatment with ivermectin vs albendazole. Southeast Asian J Trop Med Public Health 2005; 36:442-4
11. Tagawa M, Hara Y, Ejima H, Hayashi Y, Kusano K. Prophylactic efficacy of milbemycin oxime against multiple infection of dogs with Dirofilaria immitis. J Vet Med Sci 1994; 56:779-80
12. Dufour JP, Cogswell FB, Phillippi-Falkenstein KM, Bohm RP. Comparison of efficacy of moxidectin and ivermectin in the treatment of Strongyloides fulleborni infection in rhesus macaques. J Med Primatol 2006; 35:172-6
13. Janko C, Geyer J. Moxidectin has a lower neurotoxic potential but comparable brain penetration in P-glycoprotein-deficient CF-1 mice compared to ivermectin. J Vet Pharmacol Ther 2013; 36:275-84
14. Barnes EH, Dobson RJ, Stein PA, Le Jambre LF, Lenane IJ. Selection of different genotype larvae and adult worms for anthelmintic resistance by persistent and short-acting avermectin/milbemycins. Int J Parasitol 2001; 31:720-7
15. Garcia L, Bruckner D. Diagnostic Medical Parasitology. Washington, DC: American Society for Microbiology, 2001
16. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thicksmear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972; 14:397-400
17. Khieu V, Schar F, Forrer A, et al. High prevalence and spatial distribution of Strongyloides stercoralis in rural Cambodia. PLoS Negl Trop Dis 2014; 8:e2854
18. Vonghachack Y, Sayasone S, Bouakhasith D, Taisayavong K, Akkavong K, Odermatt P. Epidemiology of Strongyloides stercoralis on Mekong islands in southern Laos. Acta Trop 2015; 141:289-94
19. Sriamporn S, Pisani P, Pipitgool V, Suwanrungruang K, Kamsa-ard S, Parkin DM. Prevalence of Opisthorchis viverrini infection and incidence of cholangiocarcinoma in Khon Kaen, northeast Thailand. Trop Med Int Health 2004; 9:588-94
20. WHO Expert Committee. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ Tech Rep Ser 2002; 912: 1-57
21. Pedrique B, Strub-Wourgaft N, Some C, et al. The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment. Lancet Glob Health 2013; 1:e371-9
22. Panic G, Duthaler U, Speich B, Keiser J. Repurposing drugs for the treatment and control of helminth infections. Int J Parasitol Drugs Drug Resist 2014; 4:185-200
23. Kircik LH, Del Rosso JQ, Layton AM, Schauber J. Over 25 years of clinical experience with ivermectin: an overview of safety for an increasing number of indications. J Drugs Dermatol 2016; 15:325-32
24. Guzzo CA, Furtek CI, Porras AG, et al. Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol 2002; 42:1122-33
25. Chosidow A, Gendrel D. Safety of oral ivermectin in children. Arch Pediatr 2016; 23:204-9
26. Barda B, Coulibaly JT, Puchkov M, Huwyler J, Hattendorf J, Keiser J. Efficacy and safety of moxidectin, synriam, synriam-praziquantel versus praziquantel against Schistosoma haematobium and S. mansoni infections: a randomized, exploratory phase 2 trial. PLoS Negl Trop Dis 2016; 10:e0005008
27. Le Jambre LF, Dobson RJ, Lenane IJ, Barnes EH. Selection for anthelmintic resistance by macrocyclic lactones in Haemonchus contortus. Int J Parasitol 1999; 29:1101-11
28. Craig TM, Hatfield TA, Pankavich JA, Wang GT. Efficacy of moxidectin against an ivermectin-resistant strain of Haemonchus contortus in sheep. Vet Parasitol 1992; 41:329-33
29. Sutherland IA, Leathwick DM, Moen IC, Bisset SA. Resistance to therapeutic treatment with macrocyclic lactone anthelmintics in Ostertagia circumcincta. Vet Parasitol 2002; 109:91-9
30. Paraud C, Marcotty T, Lespine A, Sutra JF, Pors I, Devos I. Cross-resistance to moxidectin and ivermectin on a meat sheep farm in France. Vet Parasitol 2016; 226:88-92
31. Conlan JV, Sripa B, Attwood S, Newton PN. A review of parasitic zoonoses in a changing Southeast Asia. Vet Parasitol 2011; 182:22-40
32. Wen LY, Li SW, Wu LJ, et al. Clinical observation on the efficacy of ivermectin in the treatment of intestinal nematode infections. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2003; 21:113-5
33. Wen LY, Yan XL, Sun FH, Fang YY, Yang MJ, Lou LJ. A randomized, double-blind, multicenter clinical trial on the efficacy of ivermectin against intestinal nematode infections in China. Acta Trop 2008; 106:190-4
34. Xia ZH, Su YL, Yao SY, et al. Clinical observation on efficacy of ivermectin in the treatment of intestinal nematode infections. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 1992; 10:279-82
35. Wang CI, Huang XX, Zhang YQ, Yen QY, Wen Y. Efficacy of ivermectin in hookworms as examined in Ancylostoma caninum infections. J Parasitol 1989; 75:373-7
36. Williams JC, Broussard SD, Wang GT. Efficacy of moxidectin pour-on against gastrointestinal nematodes and Dictyocaulus viviparus in cattle. Vet Parasitol 1996; 64:277-83
37. Albonico M, Levecke B, LoVerde PT, et al. Monitoring the efficacy of drugs for neglected tropical diseases controlled by preventive chemotherapy. J Glob Antimicrob Resist 2015; 3:229-36